(Reuters) – U.S. President Donald Trump will announce the emergency authorization of convalescent plasma for COVID-19, a treatment that already has been given to more than 70,000 patients, the Washington Post reported (https://wapo.st/2FR4Azi), citing officials familiar with the decision.
The action will be highlighted at a news conference later on Sunday afternoon, the newspaper said.
(Reporting by Bhargav Acharya in Bengaluru; Editing by Chizu Nomiyama)
